An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Saint Joseph's Health Care London, London, Ontario, Canada
Zhanqin Zhang, Hangzhou, Zhejiang, China
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States
The General Hospital Of Guangzhou Military Command, Guangzhou, Guangdong, China
Affiliated First People's Hospital of Guangzhou, Guangzhou Medical University, Guangzhou, Guangdong, China
Erciyes university hospital, Kayseri, Turkey
Cedars-Sinai, Los Angeles, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.